Management of Relapsed/Refractory Epithelial Ovarian Cancer: Current Standards and Novel Approaches-Reference-Cited by-同舟云学术

Management of Relapsed/Refractory Epithelial Ovarian Cancer: Current Standards and Novel Approaches

Published:2007-12 Issue:4 Volume:46 Page:379-388
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Lin Hao,Changchien Chan-Chao

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference60 articles.

1. Female genital tract malignancy. Taiwan Cancer Registry, Bureau of Health Promotion, Department of Health, Republic of China, 2007. Available at: http://crs.cph.ntu.edu.tw/crs_c/annual.html

2. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

3. Responses to salvage chemotherapy in ovarian cancer: A critical need for precise definitions of the treated population;Markman;J Clin Oncol,1992

4. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer;Niloff;Am J Obstet Gynecol,1986

5. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma;Vergote;Tumour Biol,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of ERCC1 and Hormonal Receptor Expression in Ovarian Cancer;The Journal of Medical Investigation;2020

2. Next-generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug-resistant recurrent ovarian cancer;Molecular Genetics & Genomic Medicine;2018-05-24

3. High ERCC1 expression is associated with platinum-resistance, but not survival in patients with epithelial ovarian cancer;Oncology Letters;2016-06-15

4. NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis;Molecular Medicine Reports;2015-11-11

5. The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: The Kaohsiung Chang Gung experience;Taiwanese Journal of Obstetrics and Gynecology;2015-02